Dr. Shveta S. Motwani, MD

Dr. Motwani practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Motwani's NPI, 1316251135, was assigned on August 4, 2010. Dr. Motwani holds Massachusetts license 261770.

Dr. Motwani's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Motwani's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Dr. Motwani is also affiliated with Brigham and Women's Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Motwani to 1 more hospital, 3 group practices and clinics, 2 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Motwani practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Motwani's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Motwani is licensed in Massachusetts.

CMS data shows 657 Medicare services from Dr. Motwani across 8 procedure codes in 2024, for 268 Medicare patients. Medicare paid $53,644 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 268 Medicare patients who saw Dr. Motwani in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Motwani's median patient age at 70, with 54% women.

In 2024, Dr. Motwani wrote 646 Medicare Part D claims for 173 patients. 88% of them were for generic drugs. CMS names the drug for 482 of them, across 15 drugs with 11 or more claims each, at $50,015 in total drug cost. In 2023, CMS named 685 claims across 19 drugs.

Dr. Motwani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Motwani, published from 2011 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Acute Kidney Injury, Cisplatin and Antineoplastic Agents. Dr. Motwani has published most often in J Clin Oncol. Dr. Motwani's most frequent co-authors are Meghan E. Sise, MD, Ala Abudayyeh, MD and Gary C. Curhan, DSC, MD.

CMS Open Payments shows 6 general payments to Dr. Motwani from 1 drug or device company from 2022 to 2023. Consulting fees make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $10,725.